Pages that link to "Q34401345"

The following pages link to Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases (Q34401345):

Displaying 43 items.

• Toxic optic neuropathies: an updated review (Q27025010) (← links)
• Sildenafil for pulmonary hypertension (Q33213984) (← links)
• Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models (Q33837600) (← links)
• Positioning patients for spine surgery: Avoiding uncommon position-related complications (Q34047707) (← links)
• The phosphodiesterase inhibitors and non-arteritic anterior ischaemic optic neuropathy: increased vigilance is necessary (Q34626523) (← links)
• Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date (Q34918423) (← links)
• Enhancing postmarketing surveillance: continuing challenges (Q36125421) (← links)
• Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association? (Q36172099) (← links)
• Gene transfer for the therapy of erectile dysfunction: progress in the 21st century (Q36310656) (← links)
• Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. (Q36554423) (← links)
• How valid are animal models to evaluate treatments for pulmonary hypertension? (Q36577620) (← links)
• Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? (Q36689825) (← links)
• Office evaluation of male sexual dysfunction (Q36993647) (← links)
• Gene therapy for male erectile dysfunction (Q36993692) (← links)
• Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link? (Q37016354) (← links)
• Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction. (Q37180996) (← links)
• Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction. (Q37182743) (← links)
• Right-sided heart failure: diagnosis and treatment strategies (Q37223960) (← links)
• Management of erectile dysfunction in diabetes: an update for 2008. (Q37319725) (← links)
• Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction (Q37427312) (← links)
• Newer phosphodiesterase inhibitors: comparison with established agents (Q37881314) (← links)
• Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION): A Review and Update on Animal Models. (Q38766831) (← links)
• A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil (Q38779720) (← links)
• Nonarteritic ischaemic optic neuropathy (NAION) after 36 h of intake of sildenafil citrate: first Egyptian case. (Q38986974) (← links)
• Bilateral Anterior Ischaemic Optic Neuropathy in a Child on Continuous Peritoneal Dialysis: Case report and literature review (Q39047963) (← links)
• Bilateral blindness secondary to optic nerve ischemia from severe amlodipine overdose: a case report (Q41228633) (← links)
• A case of recurrent transient monocular visual loss after receiving sildenafil. (Q41975465) (← links)
• Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction (Q42835834) (← links)
• Can erectile dysfunction drug use lead to ischaemic optic neuropathy? (Q42835931) (← links)
• Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment (Q42944761) (← links)
• There have been inadequate warnings that erectile dysfunction drugs can cause blindness (Q43766674) (← links)
• Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers (Q45332002) (← links)
• Cilioretinal artery and central retinal vein occlusion after sildenafil use. (Q46667410) (← links)
• Protective effect of sildenafil (Viagra) in transient spinal cord ischemia (Q46838130) (← links)
• Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN) (Q46924392) (← links)
• Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men. (Q47129573) (← links)
• Clinical assessment of the optic disc at risk of nonarteritic anterior ischaemic optic neuropathy. (Q53066013) (← links)
• Thrombophilic risk factors in the pathogenesis of non-arteritic anterior ischemic optic neuropathy patients (Q82930067) (← links)
• Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a haemodialysis patient (Q83864156) (← links)
• Editorial Comment (Q87958634) (← links)
• Ocular Side Effects of Systemic Drugs Used in Dermatology (Q92381277) (← links)
• Association Study of MTHFR Polymorphisms with Nonarteritic Anterior Ischemic Optic Neuropathy in a Spanish Population (Q98291429) (← links)
• Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review (Q98386705) (← links)